These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2831557)

  • 1. Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine.
    Byerley WF; McConnell EJ; McCabe RT; Dawson TM; Grosser BI; Wamsley JK
    Psychopharmacology (Berl); 1988; 94(1):141-3. PubMed ID: 2831557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors.
    Wong DT; Reid LR; Bymaster FP; Threlkeld PG
    J Neural Transm; 1985; 64(3-4):251-69. PubMed ID: 3003252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of beta-adrenergic receptors in rat frontoparietal cortex.
    Byerley WF; McConnell EJ; McCabe RT; Dawson TM; Grosser BI; Wamsley JK
    Brain Res; 1987 Sep; 421(1-2):377-81. PubMed ID: 2825912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strong influence of serotonin axons on beta-adrenergic receptors in rat brain.
    Stockmeier CA; Martino AM; Kellar KJ
    Science; 1985 Oct; 230(4723):323-5. PubMed ID: 2996132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine.
    Mishra R; Janowsky A; Sulser F
    Eur J Pharmacol; 1979 Dec; 60(4):379-82. PubMed ID: 316774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine.
    Baron BM; Ogden AM; Siegel BW; Stegeman J; Ursillo RC; Dudley MW
    Eur J Pharmacol; 1988 Sep; 154(2):125-34. PubMed ID: 2465908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
    Wong DT; Bymaster FP; Reid LR; Threlkeld PG
    Biochem Pharmacol; 1983 Apr; 32(7):1287-93. PubMed ID: 6303355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. delta 9-Tetrahydrocannabinol-induced changes in beta-adrenergic receptor binding in mouse cerebral cortex.
    Hillard CJ; Bloom AS
    Brain Res; 1982 Mar; 235(2):370-7. PubMed ID: 6329417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of REM sleep deprivation and desipramine on beta-adrenergic binding sites in rat brain.
    Radulovacki M; Micovic N
    Brain Res; 1982 Mar; 235(2):393-6. PubMed ID: 6329418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.
    Mousseau DD; McManus DJ; Baker GB; Juorio AV; Dewhurst WG; Greenshaw AJ
    Cell Mol Neurobiol; 1993 Feb; 13(1):3-13. PubMed ID: 8384528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.
    Goodnough DB; Baker GB
    J Neurochem; 1994 Jun; 62(6):2262-8. PubMed ID: 8189233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on the rate of recovery of beta-adrenergic receptors in rat brain following desmethylimipramine-induced subsensitivity.
    Greenberg LH; Brunswick DJ; Weiss B
    Brain Res; 1985 Feb; 328(1):81-8. PubMed ID: 2982468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.